_PRIVATE_LIMITED.webp)
Jivalogics Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 08-01-2025
- Paid Up Capital ₹ 0.50 M
as on 08-01-2025
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 Cr
as on 08-01-2025
- Satisfied Charges ₹ 4.50 M
as on 08-01-2025
- Revenue 3.66%
(FY 2022)
- Profit 13.22%
(FY 2022)
- Ebitda 9.57%
(FY 2022)
- Net Worth 26.86%
(FY 2022)
- Total Assets 32.95%
(FY 2022)
About Jivalogics Biotech (India)
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.50 Cr. The company has closed loans amounting to ₹4.50 M, as per Ministry of Corporate Affairs (MCA) records.
Purushotham Marupaka, Akshay Marapaka, and Pushkar Marapaka serve as directors at the Company.
- CIN/LLPIN
U01119TG2010PTC071593
- Company No.
071593
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Jivalogics Biotech (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshay Marapaka  | Managing Director | 01-Nov-2019 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pushkar Marapaka | Director | 31-Dec-2020 | Current |
| Purushotham Marupaka | Director | 09-Dec-2010 | Current |
Financial Performance of Jivalogics Biotech (India).
Jivalogics Biotech (India) Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.66% increase. The company also saw a substantial improvement in profitability, with a 13.22% increase in profit. The company's net worth Soared by an impressive increase of 26.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jivalogics Biotech (India)?
In 2022, Jivalogics Biotech (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Loukya Hybrid Seeds Private LimitedActive 5 years 10 monthsAkshay Marapaka and Pushkar Marapaka are mutual person
Charges (Loans)
₹35.00 M
₹4.50 M
Charges Breakdown by Lending Institutions
- Others : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2023 | Others | ₹3.50 Cr | Open |
| 16 Jan 2015 | Indian Bank | ₹4.50 M | Satisfied |
How Many Employees Work at Jivalogics Biotech (India)?
Unlock and access historical data on people associated with Jivalogics Biotech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jivalogics Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jivalogics Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
